Article summary
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research organization ICON will bring Anthropic's Claude AI tool into clinical trials involving drug development. The post Weekly Psychedelic Policy Briefing β August 14, 2026 first appeared on Lucid News.
Continue to the original publication for the complete article.